BANK VONTOBEL/CALL/PFIZER INC/36/0.1/20.09.24 Share Price

Warrant

DE000VM3RDP8

Market Closed - Deutsche Boerse AG 18:45:00 27/06/2024 BST
0.004 EUR +33.33% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/36/0.1/20.09.24
1 month-69.23%
3 months-80.00%
Date Price Change
27/06/24 0.004 +33.33%
26/06/24 0.003 0.00%
25/06/24 0.003 0.00%
24/06/24 0.003 -25.00%
21/06/24 0.004 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 06:45 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM3RDP
ISINDE000VM3RDP8
Date issued 09/10/2023
Strike 36 $
Maturity 20/09/2024 (85 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.24
Lowest since issue 0.002
Delta0.07x
Omega 14.47
Premium30.29x
Gearing215.92x
Moneyness 0.7703
Difference Strike 8.2 $
Difference Strike %+22.78%
Spread 0.016
Spread %80.00%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.8 USD
Average target price
31.92 USD
Spread / Average Target
+14.80%
Consensus